MIRA Pharmaceuticals, Inc. (MIRA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 35.78M |
| Enterprise Value | 29.43M |
| P/E Ratio | -0.66 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 4.27 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -3.58 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.04 |
| Return On Equity | -1.41 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -10.44M |
| Net Income | -10.44M |
| Diluted EPS | -1.35 |
| Total Cash | 9.41M |
| Total Cash/Share | 0.22 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 82.16 |
| Book Value Per Share | 0.22 |
| 52-Week Change | -18.7 |
| 52-Week High | 2.45 |
| 52-Week Low | 0.9 |
| Moving Average 50 Days | 1.02 |
| Moving Average 200 Days | 1.27 |
| Average Volume | 139,359 |
| Shares Outstanding | 42.02M |
| % Held by Institutions | 9.06 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |